Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Repifermin: Began Phase II trial

(Clinical results, B12; Preclinical data, B17)

Human Genome

Read the full 80 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE